細胞死制御剤による重粒子放射線防護効果のマウス個体レベルでの検討
明典 森田, Shintaro Ochi(Tokushima University), 卓志 下川, Takanori Katsube(National Institutes for Quantum Science and Technology), Mitsuru Nenoi, Kaoru Tanaka(Kindai University), Morita Akinori, 正弘 村上, 薫 田中, Masahiro Murakami, Bing Wang, 充 根井, 冰 王, 進太郎 越智, 孝則 勝部, Takashi Shimokawa(National Institutes for Quantum Science and Technology)
Institutional Repositories DataBase (IRDB)
April 22, 2019
Cited by 0
Related Papers
Association of Immune-Related Adverse Events With Nivolumab Efficacy in Non–Small-Cell Lung Cancer
|JAMA Oncology|2017|1k
Tumor immune microenvironment and nivolumab efficacy in EGFR mutation-positive non-small-cell lung cancer based on T790M status after disease progression during EGFR-TKI treatment
|Annals of Oncology|2017|294
Impact of EGFR-TKI Treatment on the Tumor Immune Microenvironment in <i>EGFR</i> Mutation–Positive Non–Small Cell Lung Cancer
|Clinical Cancer Research|2020|244
Peripheral Blood Biomarkers Associated with Clinical Outcome in Non–Small Cell Lung Cancer Patients Treated with Nivolumab
|Journal of Thoracic Oncology|2017|227
Space Radiation Biology for “Living in Space”
|BioMed Research International|2020|181